Peninsula Pharmaceuticals Overview
- Year Founded
-
2001
- Status
-
Acquired/Merged
- Employees
-
21
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$300M
Peninsula Pharmaceuticals General Information
Description
Developer of antibiotics. The company is a biopharmaceutical business focused on developing and commercializing broad-spectrum antibiotics to treat life-threatening infections, including ventilator-assisted pneumonia.
Contact Information
Corporate Office
- 1751 Harbor Bay Parkway
- Alameda, CA 94502
- United States
Corporate Office
- 1751 Harbor Bay Parkway
- Alameda, CA 94502
- United States
Peninsula Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 30-Jun-2005 | $300M | Completed | Generating Revenue | ||
| 5. Early Stage VC | 24-Feb-2005 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 17-Dec-2003 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 19-Nov-2003 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 28-Oct-2002 | $22.1M | $22.6M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 05-Mar-2002 | $495K | $495K | Completed | Generating Revenue |
Peninsula Pharmaceuticals Patents
Peninsula Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20050065141-A1 | Lung infections; particularly in cystic fibrosis patients; pneumonia; bronchitis | Inactive | 31-Jul-2003 |
Peninsula Pharmaceuticals Signals
Peninsula Pharmaceuticals Former Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CDIB BioScience Venture Management | Venture Capital | Minority | ||
| Canaan Partners | Venture Capital | Minority | ||
| DBL Partners | Venture Capital | Minority | ||
| Domain Associates | Venture Capital | Minority | ||
| Mitsubishi International | Corporation | Minority |
Peninsula Pharmaceuticals Acquisitions (1)
Peninsula Pharmaceuticals’s most recent deal was a Merger/Acquisition with Domain AntiBacterial Acquisition. The deal was made on 01-Feb-2003.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Domain AntiBacterial Acquisition | 01-Feb-2003 | Merger/Acquisition | Other Healthcare Services |
Peninsula Pharmaceuticals FAQs
-
When was Peninsula Pharmaceuticals founded?
Peninsula Pharmaceuticals was founded in 2001.
-
Where is Peninsula Pharmaceuticals headquartered?
Peninsula Pharmaceuticals is headquartered in Alameda, CA.
-
What is the size of Peninsula Pharmaceuticals?
Peninsula Pharmaceuticals has 21 total employees.
-
What industry is Peninsula Pharmaceuticals in?
Peninsula Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Peninsula Pharmaceuticals a private or public company?
Peninsula Pharmaceuticals is a Private company.
-
What is the current valuation of Peninsula Pharmaceuticals?
The current valuation of Peninsula Pharmaceuticals is .
-
What is Peninsula Pharmaceuticals’s current revenue?
The current revenue for Peninsula Pharmaceuticals is .
-
How much funding has Peninsula Pharmaceuticals raised over time?
Peninsula Pharmaceuticals has raised $106M.
-
Who are Peninsula Pharmaceuticals’s investors?
CDIB BioScience Venture Management, Canaan Partners, DBL Partners, Domain Associates, and Mitsubishi International are 5 of 8 investors who have invested in Peninsula Pharmaceuticals.
-
When was Peninsula Pharmaceuticals acquired?
Peninsula Pharmaceuticals was acquired on 30-Jun-2005.
-
Who acquired Peninsula Pharmaceuticals?
Peninsula Pharmaceuticals was acquired by Johnson & Johnson.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process